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S54 Lupus Nephropathybut tended to present a higher prevalence of fever, acute kidney injury,
oliguria or anuria. During a median follow-up of 55.0 months, 107
(12.2%) patients had doubling of serum creatinine or ESRD (male 7.9% vs
female 8.5%) and 114 (13.0%) patients died (male 14.9% vs female 7.8%).
Regarding patient survival, compared with female patients, males had
no difference in renal outcome but had significantly higher mortality
than females.
Conclusion: The male lupus nephritis patients had worse renal function
compared with female patients. Moreover, male patients had significantly
higher mortality.http://dx.doi.org/10.1016/j.hkjn.2015.08.139
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The Role of Interaction Between Renal Proximal Tubular Epithelial Cells
and T Lymphocytes in the Pathogenesis of Tubulointerstial
Inflammation in Lupus Nephritis
D. Y. H. Yap, S. Yung, T. M. Chan
The University of Hong Kong, Hong Kong
Background: Renal proximal tubular epithelial cells (PTEC) and T lympho-
cytes assume pathogenic roles in tubulointerstitial inflammation in lupus
nephritis (LN). Their interaction in such inflammatory process remains
unclear.
Methods: CD4+ and CD8+ T cells were isolated from LN patients with (Group
I) or without (Group II) moderate to severe tubulointerstitial inflammation,
and co-incubated with PTEC in a transwell system. The level of cytokines
in the culture media were measured after 72 hours of co-culture and
compared between Group I and II patients.
Results: Twelve proliferative LN patients with (Group I; n Z 7) or without
(Group II; n Z 5) moderate to severe tubulointerstitial inflammation were
included. Group I patients showed significantly higher levels of RANTES
(p Z 0.002, 0.015 and 0.014) but lower IL-10 (p Z 0.018, 0.015 and 0.022)
when PTEC were co-cultured with their CD4+ T cells, CD8+ T cells or with
both CD4+ and CD8+ T cells. Group I also demonstrated higher levels of
MCP-1 (p Z 0.016 and 0.042) when PTEC were co-cultured with their CD8+
T cells or with both CD4+ and CD8+ T cells. There is no statistically significant
difference in IL-6 or IL-8, although Group I showed numerically much higher
IL-6 levels.
Conclusion: A significant increase in RANTES and MCP-1 and a decrease in IL-
10 levels were observed upon PTEC/T cell interaction in LN patients with
moderate to severe tubulointerstitial inflammation, and hence suggest the
putative roles of these cytokines in mediating tubulointerstitial inflamma-
tion in LN.http://dx.doi.org/10.1016/j.hkjn.2015.08.140
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Risk Factors of Renal Relapse in the Era of Effective Immunosuppressive
Treatments Among Chinese Lupus Nephritis Patients
D. Y. H. Yap, T. M. Chan
The University of Hong Kong, Hong Kong
Objective: Repeated renal flares jeopardize the long-term kidney function
in lupus nephritis (LN) patients. This study investigated the risk factors for
relapse in the era of effective immunosuppressive treatments.
Methods: All LN patients who were followed up in Queen Mary Hospital dur-
ing the period of 1 January 1983 to 31 December 2013 were reviewed. Epi-
sodes of renal relapses were identified and the risk factors for relapse
were analyzed. The risk of relapse was also analyzed according to the era
before (1983e1997) and after (1998e2013) the availability of mycophenolic
acid (MPA) treatment in our centre.Results: A total of 346 episodes of renal flares occurred in 184 patients (mean
follow-up duration 195.3  94.4 months). Multivariate analysis showed that
age (OR 0.97; 95% CI 0.943e0.998; pZ 0.038), higher serum creatinine on pre-
sentation (OR 0.992; 95% CI 0.985e0.999; PZ 0.019),use of mycophenolic acid
(MPA) as maintenance treatment (OR 0.322; 95% CI 0.0109e0.953; PZ 0.041)
and achievement of complete remission after induction therapy (OR 0.394;
95% CI 0.175e0.886; PZ 0.024) were factors associated with lower risk of renal
relapse. The choice of induction therapy, proteinuria and serological parame-
ters on presentation did not affect the risk of subsequent flares (all P> 0.05).
Rates of renal relapse were 0.044 and 0.024 relapse per patient-year before
and after the availability of MPA treatment (P< 0.001). Patients who received
prednisolone and MPA maintenance showed better relapse-free survival those
on prednisolone and azathioprine (AZA) (83% vs. 68%, 66% vs. 42% and 62% vs.
37% at 5, 10 and 15 years; PZ 0.048).
Conclusion: The risk of renal flare was low in the era of effective immuno-
suppressive treatments. The use of MPA as maintenance treatment might
have contributed to lower risk of LN relapse and appeared to be more effec-
tive than AZA to prevent flares.http://dx.doi.org/10.1016/j.hkjn.2015.08.141
0168
Variation and Clinical Significance of Circulation Annexin II in Patients
with Systemic Lupus Erythematosus
H. K. Hu, L. G. Y. Lu
The First Affiliated Hospital of Soochow University, Suzhou, China
Objective: To compare the level of annexin II in patients with systemic lupus
erythematosus, diabetic nephropathy, chronic glomerulonephritis and in
normal control group, to explore the significance of the annexin II in sys-
temic lupus erythematosus.
Methods: Thirty-five cases of patients with systemic lupus erythematosus,
10 cases of patients with diabetic nephropathy, and 10 cases of patients
with chronic glomerulonephritis were enrolled in this study; 20 cases of
healthy controls were also enrolled. Circulating annexin II in white blood
cells was detected by flow cytometry. Student’s t test, variance analysis
and linear correlation analysis were used for statistics.
Results: Compared with healthy control cases, the level of annexin II in
white blood cells in SLE patients (7.10  2.89%) and DN patients
(7.95  3.72%) were significantly lower than that in healthy controls
(P< 0.01, P< 0.05). In the SLE group, the level of annexin II in patients
who were more active (SLEDAI  9) decreased more than in those who
were less active (SLEDAI < 9; P< 0.05). As for annexin II, a positive correla-
tion was found with serum albumin (rZ 0.439, p< 0.01), negtive correlation
was found with urine protein/urine creatinine (r Z 0.382, p< 0.05), SLE-
DAI (r Z 0.417, p< 0.05), and D-dimer (r Z 0.336, p< 0.05).
Conclusion: The level of annexin II is decreased in patients with systemic
lupus erythematosus. It can be used as a reflection of the abnormality of
the coagulation and fibrinolytic systems. It may be used as a good indicator
of the prothrombotic state in SLE patients, and be helpful in judging the ac-
tivity and therapeutic effect of the disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.142
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Effect of Rituximab on Serum Levels of Anti-C1q Antibodies and
Antineutrophil Cytoplasmic Autoantibodies in Refractory Severe Lupus
Nephritis
Xiaozhou Hu, Jin Zhang, Zhangzheng Zhao, Shaoting Wang
5th Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Objectives: To analyze and compare the effects of rituximab (RTX) and
cyclophosphamide (CTX) on the serum levels of anti-C1q antibodies and
Lupus Nephropathy S55antineutrophil cytoplasmic autoantibodies (ANCA) in assessing the prognosis
of refractory severe lupus nephritis (LN).
Methods: Eighty-four cases of refractory severe LN were randomly divided into
twogroupsof 42caseseach:CTXgroupandRTXgroup(CTX+RTX)duringFebruary
2010 to February 2014 in our hospital and First Affiliated Hospital of Zhengzhou
University. Changes in serum levels of anti-C1q antibodies and ANCA in the two
groups were examined, and efficacies of the drugs were compared.
Results: The total efficacy of RTX group was found to be 83.3 %, which was
significantly higher than that of the CTX group, 57.1 % (p< 0.05). The serum
anti-C1q antibodies and ANCA were decreased to 11.9% and 26.2 % in the
RTX-treated group, which was significantly lower than those observed in
the CTX-treated patients (21.4% and 69.0 % respectively) (p< 0.05). The
clinical indices of LN were significantly improved in the two groups after
the treatment. However, the urinary protein, albumin, complement C3,
the percentage of CD19+ B cells, and SLEDAI scores in the RTX group were
significantly lower than those in the CTX group (p< 0.05).
Conclusion: RTX plus CTX showed a better therapeutic efficacy compared to
single CTX, and it significantly improved the prognosis of refractory and se-
vere LN. Anti-C1q antibody and ANCA level may be valuable biomarkers for
the prognosis of LN.http://dx.doi.org/10.1016/j.hkjn.2015.08.143
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Low-dose Mycophenolate Mofetil in the Treatment of Lupus Nephritis
Ling An, Wenbo Hu
The Qinghai Provincial People’s Hospital, Qinghai, China
Objective: To evaluate the efficacy of low-dose mycophenolate mofetil
(MMF) combined with low-dose prednisone in the treatment of lupus
nephritis.
Methods: Forty patients (5 males, 35 females) with lupus nephritis (10 in
class III, 18 in class IV, 12 in class V+IV) were treated with low-dose MMF
(1.0 g/d to 1.5 g/d) combined with prednisone 0.35 mg/(kg$d), course of
12 months, changes were observed before and after treatment in January,
March, June, September, December liver and kidney function, blood uric
acid, cholesterol, blood sugar, blood coagulation, urine, 24-hour urinary pro-
tein, serum antibody levels and other indicators.
Results: Complete remission in 28 patients (70%), partial remission in 8 pa-
tients (20%), and no relief in 4 patients (10), the total efficiency of 90%. Low-
doses of MMF combined with low-dose prednisone treatment of lupus
nephritis had no effect on liver function, creatinine, glucose, uric acid,
white blood cells, platelets. Treatment 1e3 months, plasma protein
increased, decreased 24-hour urinary protein, blood lipid levels decreased
(P< 0.05), 6e12 months after treatment significantly increased serum
albumi hemoglobin, and 24-hour urinary protein, blood lipid levels, serum
antibody levels were significantly decreased (P< 0.01). Only 1 case of infec-
tion occurred in 40 patients discontinued.
Conclusion: Low-dose MMF in combination with low-dose prednisone is
effective in treating lupus nephritis, has better treatment safety, and low
incidence of infection.http://dx.doi.org/10.1016/j.hkjn.2015.08.144
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Functional MRI Used to Evaluate Renal Hypoxia in Mice with Lupus
Nephritis
Xiao Li1, Yan Liu1, Xueqin Xu2, Simeng Liu1, Nan Chen1
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School of Medicine, Shanghai, China
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School of Medicine, Shanghai, China
Objectives: To investigate the utility of diffusion weighted imaging (DWI)
and blood oxygen level-dependent (BOLD) MR imaging in the assessment ofrenal hypoxia in an experimental model of mice with established lupus
nephritis (LN).
Methods: Sixteen-week-old female MRL/lpr mice (n Z 13) were studied
and 14 week old male C57BL/6 mice (n Z 10) served as controls. The
mice underwent coronal echo-planar DWI and BOLD MR imaging of the
kidneys. Hypoxyprobe was administed intraperitoneally to the mice 1
hour before they were sacrificed. The distribution of HypoxyprobeTM-1,
hypoxia-inducible factor 1a (HIF-1a) and heme oxygenase-1 (HO-1) in
renal tissues were detected by immunohistochemical analyses and West-
ern blot. The apparent diffusion coefficient (ADC) and R2* value of the
kidneys was calculated with b values of 0 and 500 s/mm2. The relation be-
tween the renal hypoxia parameters and the ADCs or R2* values were
evaluated.
Results: Glomerular mesangial proliferation and basement membrane
thickening, tubular epithelial cells damage, interstitial leukocytes infiltra-
tion, especially the large accumulation of inflammatory cells surrounding
small vessels were observed in MRL/lpr mice. It was found that Hypoxypro-
beTM-1, HIF-1a and HO-1 distributed widely in the renal tissues of MRL/lpr
mice, and closely associated with the renal tubulointerstitial lesions. The
mean ADC values of kidneys in MRL/lpr mice were 1.52  0.27 x 10－
3 mm2/s, the mean R2* values of the renal cortex and medulla were
30.95  4.59/sec and 23.43  3.06/sec respectively, which were all signif-
icantly lower than that in C57BL/6 mice (p Z 0.037, p Z 0.03 and
pZ 0.043, respectively). The mean R2* values were negatively correlated
with the degree of tubulointerstitial lesions and the expression of hypoxia
parameters.
Conclusion: The results suggested that renal hypoxia is one of the key fac-
tors leading to renal tubulointerstitial lesion, and functional MRI may used to
monitor renal hypoxia in LN.
*Funding was provided by the National Natural Science Foundation of China
(81170671).http://dx.doi.org/10.1016/j.hkjn.2015.08.145
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Monocyte Chemotactic Protein-1, Fractalkine and Receptor for
Advanced Glycation End Products in Different Pathological Types of
Lupus Nephritis and Their Value in Predicting Treatment Prognosis
L. Lan, F. Han, J. H. Chen
Kidney Disease Center, The First Affiliated Hospital, College of Medicine,
Zhejiang University, Hangzhou, China
Objective: Early diagnosis is important for the outcome of lupus nephritis
(LN). But the pathological type of LN is closely related to the clinical man-
ifestations, and hence the treatment of LN depends on different patholog-
ical types. To assess the level of monocyte chemotactic protein (MCP-1),
fractalkine (Fkn), and receptor for advanced glycation end product
(RAGE) in different pathological types of lupus nephritis and to explore
the value of these biomarkers in predicting the prognosis of lupus
nephritis.
Methods: In the patients included in this study, through renal biopsy, class III
and class IV were defined as proliferative group, class V as nonproliferative
group, class V+III and class V+IV as mixed group. During the follow-up, 40 of
the 178 enrolled patients were found to have poor response to standard
immunosuppressant therapy. The level of markers in the different response
groups was tested.
Results: The levels of urine and serum MCP-1, urine and serum Fkn, and
serum RAGE were higher in the proliferative group, and lower in the nonpro-
liferative group, and the difference was significant. The levels of urine and
serum MCP-1 and serum RAGE were lower in the poor response group; the
difference was also significant. The relationship between urine MCP-1, urine
and serum Fkn with the Systemic Lupus Erythematosus Disease Activity Index
was proved.
Conclusion: The concentration of cytokines MCP-1, Fkn, and RAGE may be
correlated with the nuclear factor-kappaB pathway. The urine and serum
MCP-1 and serum RAGE may help in predicting the prognosis before standard
immunosuppressant therapy.
